Dr. Daniel Landsburg is an Associate Professor of Clinical Medicine, Department of Medicine, University of Pennsylvania.

He received his BA from the University of Pennsylvania followed by his MD from Temple University School of Medicine. He completed his Internal Medicine residency and Hematology/Oncology fellowship at the Hospital of the University of Pennsylvania.

His clinical practice is focused in B cell lymphomas as well as CART therapy and autologous stem cell transplantation, and his primary research interest involves the use of molecular testing to risk-stratify and guide use of targeted therapies for patients diagnosed with aggressive B cell lymphomas.

He serves as the Medical Director of Infusion Services and the Physician Leader of the Oncology Clinical Effectiveness Team for the Hospital of the University of Pennsylvania. He also leads quality improvement education for the Hematology/Oncology fellowship program and is a core faculty member for the Internal Medicine residency program for quality improvement and patient safety education at the Hospital of the University of Pennsylvania.